CDSCO Panel Approves IQVIA RDS Protocol Amendment Proposal for Survodutide study Dr. Divya Colin2 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel grants GSK's Protocol Amendment Proposal To Study Belantamab mafodotin Dr. Divya Colin1 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves Pfizer's Protocol Amendment Proposal to Study Aztreonam and Avibactam Dr. Divya Colin21 Sept 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
CDSCO Panel Approves Sanofi's Protocol Amendment proposal for Fitusiran study Dr. Divya Colin7 Sept 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves AstraZeneca's Protocol Amendment proposal for COPD drug Tozorakimab Dr. Divya Colin5 Sept 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the clinical trial...
CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
50% of trial sites should be Govt sites, more subjects should be enrolled from Govt sites: CDSCO panel tells AstraZeneca on Baxdrostat study Dr. Divya Colin15 Aug 2024 5:45 PM ISTNew Delhi: In line with the drug major AstraZeneca's protocol amendment proposal to study the cardiovascular drug Baxdrostat, the Subject Expert...
CDSCO Panel Approves IQVIA RDS's Protocol Amendment Proposal for Spesolimab study Dr. Divya Colin11 Aug 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved IQVIA RDS's...
CDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Antidiabetic Drug Tirzepatide Dr. Divya Colin4 Aug 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
CDSCO panel Approves Novartis Protocol Amendment proposal to study inclisiran Dr. Divya Colin4 Aug 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee SEC functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
CDSCO Panel Approves Novo Nordisk's Protocol Amendment proposal to study Somapacitan Dr. Divya Colin31 July 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major Novo...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment Proposal to Study JNJ-77242113 Dr. Divya Colin19 July 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
